Bed nucleus of the stria terminalis-nucleus accumbens stimulation for depression: A randomized, double-blind, crossover trial
Clinical Snapshot
PICO Framework
| P — Population | Patients with treatment-resistant depression (TRD) |
| I — Intervention | Deep brain stimulation (DBS) targeting bed nucleus of the stria terminalis (BNST) and nucleus accumbens (NAc) |
| C — Comparator | Sham DBS (inactive stimulation) |
| O — Outcomes | Primary: Hamilton Depression Scale-17 (HAMD) scores; Secondary: anxiety, quality of life, disability measures, adverse events |
Bottom Line
This randomized crossover trial demonstrates that DBS targeting BNST-NAc produces clinically meaningful improvements in treatment-resistant depression, with a 10.1-point HAMD reduction and 50% response rate. However, serious adverse events including suicide and seizure highlight significant safety concerns. The intervention requires highly specialized expertise and infrastructure, limiting applicability to select tertiary centers. While promising for severe, refractory cases, the risk-benefit profile needs careful consideration, and longer-term safety and efficacy data are essential. This represents an experimental therapy that should only be considered in specialized centers with appropriate ethics oversight and patient selection protocols.
Key Findings
P Value: p < 0.001
Effect Size: 10.1 point reduction in HAMD-17 (clinically significant)
Primary Outcome: Mean decrease in HAMD-17 scores of 10.1 points
Nnt Or Sensitivity: 50% response rate (NNT = 2 for response)
Confidence Interval: Not reported
Clinical Application
Limited to specialized neurosurgical centers with DBS expertise and multidisciplinary psychiatric teams Would require TGA approval for this indication; limited to major tertiary centers; not currently PBS-funded; would need RANZCP and neurosurgical society guidelines Highly selected patients with severe, treatment-resistant depression who have failed multiple conventional therapies
Abstract
Although deep brain stimulation (DBS) shows potential in treatment-resistant depression (TRD), the efficacy remains controversial. To assess the efficacy of DBS of the bed nucleus of the stria terminalis (BNST) and nucleus accumbens (NAc) for TRD, we conduct a randomized, double-blind, crossover trial after an open-label optimization stage. Stimulation leads to a mean decrease in the Hamilton Depression Scale-17 (HAMD) scores of 10.1 points (p < 0.001) with a 50% response rate at the end of the open-label stage. Anxiety, quality of life, and disability are also improved. The HAMD scores are significantly lower in patients during active DBS than during sham DBS (p < 0.001). Serious adverse events include suicide (1 patient) and seizure (1 patients). With individual stimulation analysis, we identify optimal stimulation sites, fiber tracts, and functional networks (false discovery rate [FDR] p < 0.05). This study demonstrates the efficacy and safety of BNST-NAc DBS for TRD and reveals optimal brain targets for stimulation. This study was registered at ClinicalTrials.gov (NCT04530942).
References
- 1.Lai, Y., Zhang, Y., Wang, Y., Wang, L., Dai, L., Ye, K., Lv, X., Wang, F., Zhang, J., Zhao, Y., Hu, K., Huang, P., Zhang, X., Qiu, X., Pan, Y., Liu, W., Liu, Q., Zhang, C., Fang, Y., Ye, Z., Yuan, T. F., Li, D., Li, N., Lozano, A. M., Voon, V., Zhan, S., & Sun, B. (2026). Bed nucleus of the stria terminalis-nucleus accumbens stimulation for depression: A randomized, double-blind, crossover trial. Cell Reports Medicine, 15(4), 102711. https://doi.org/10.1016/j.xcrm.2026.102711
Related Research
Journal of psychiatric research
Systematic review of machine learning and deep learning models for EEG-based detection of depression.
2 Aug 2026
Sleep medicine reviews
Artificial intelligence in sleep medicine I: Diagnosis, treatment, care, and research
2 Aug 2026
International journal of yoga therapy
Randomized Controlled Trial on the Effect of Yoga on Anxiety Severity, Quality of Life, and Biomarkers in Individuals with Anxiety Disorder
31 July 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service